TITLE

NICE guidelines for the use of drug-eluting stents: how do we establish worth?

AUTHOR(S)
de Belder, M. A.
PUB. DATE
December 2008
SOURCE
Heart;Dec2008, Vol. 94 Issue 12, p1646
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the quantifying process by which the National Institute for Health and Clinical Excellence (NICE) has conducted for its new guidance and recommendations on the use of drug-eluting stents in coronary angioplasty in Great Britain. It mentions that the process by which NICE performs its appraisals includes a call for evidence from all stakeholders as well as the production of an assessment report and an appraisal consultation document.
ACCESSION #
36855632

 

Related Articles

  • New NICE report may clear fog that hangs over DES use in UK. Brosky, John // Cardiovascular Devices & Drugs;Feb2008, Vol. 14 Issue 2, p16 

    The article reports on the move of the National Institute for Health and Clinical Excellence (NICE) in Great Britain to reverse its earlier position opposing the use of drug-eluting stents, clearing the way for reimbursement of such interventions in the market. In the absence of appeals against...

  • Effect of Direct Stent Implantation on QTc Dispersion. Atmaca, Yusuf; Ozdol, Cagdas; Ertas, Fatih; Altin, Timucin; Giilec, Sadi; Oral, Dervis // Angiology;Mar/Apr2005, Vol. 56 Issue 2, p143 

    The aim of this study was to evaluate whether direct stenting is superior to conventional stent implantation technique with respect to QTc dispersion in prospectively selected patients with simple lesion morphology and class II stable angina undergoing elective coronary stenting. One hundred...

  • Angioplasty-Induced Pseudoaneurysm Successfully Treated with a Palmaz Stent. Castañeda, Flavio; Wright, Jamey D.; Méndez, Alejandro // Angiology;Nov1995, Vol. 46 Issue 11, p1021 

    Pseudoaneurysm formation and vessel rupture are considered rare complications of percutaneous transluminal angioplasty (PTA), and few reported cases exist in the literature. The true incidence of pseudoaneurysm formation is unknown, for follow-up angiography is not routinely performed unless...

  • Bivalirudin in acute myocardial infarction: NICE guidance. Stone, Gregg W. // Heart;Mar2012, Vol. 98 Issue 6, p435 

    The author discusses the positive clinical outcomes of bivalirudin in ST-segment elevation myocardial infarction (STEMI) patients treated with percutaneous coronary intervention (PCI). He informs about the numerous limitations of unfractionated heparin (UFH) used in PCI treatment. He states that...

  • NICE provides guidance on several diseases.  // PharmacoEconomics & Outcomes News;11/14/2009, Issue 591, p8 

    The article reports on the release of new guidance by the British National Institute for Health and Clinical Excellence (NICE) in 2009 on the use of prasugrel for patients undergoing coronary angioplasty, the use of topotecan for cervical cancer and the treatment of depression. Healthcare...

  • UK panel turns down Cordis' appeal of DES reimbursement. BROSKY, JOHN // Cardiovascular Devices & Drugs;Sep2008, Vol. 14 Issue 9, p17 

    The article reports on the rejection by a panel of Britain's National Institute for Health and Clinical Excellence (NICE) of an appeal filed by Cordis regarding reimbursement for drug-eluting stents (DES) used to treat coronary artery disease. NICE issued a guidance that DES use would be...

  • NICE rejects Cordis' appeal of 'perverse' stent guidance. Brosky, John // Medical Device Daily;7/29/2008, Vol. 12 Issue 145, p1 

    The article reports that the National Institute for Health and Clinical Excellence (NICE) has turned down an appeal by Cordis regarding the methodology used in setting guidelines for the use of drug-eluting stents (DES) for the treatment of coronary artery disease in Great Britain. NICE chief...

  • Carotid artery stenting: the 2011 NICE guidelines. Neequaye, Simon K.; Halliday, Alison W. // Heart;Feb2012, Vol. 98 Issue 4, p274 

    The article summarizes the guidelines on carotid artery stenting (CAS) published by Great Britain's National Institute for Health and Clinical Excellence (NICE) in April 2011. NICE has described the current evidence base for safety and efficacy with CAS as adequate to support the use of this...

  • Commentary on drug-eluting stents: to use or not to use—that is the question! Pfisterer, Matthias E. // Heart;Dec2008, Vol. 94 Issue 12, p1648 

    The article presents the author's perspectives on the new guidance by the Great Britain National Institute for Health and Clinical Excellence (NICE) regarding the use of drug-eluting stents (DES) in percutaneous coronary intervention for the treatment of coronary artery disease. He contends that...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics